MedPath

Treatment for depression and anxiety in visually impaired older adults.

Conditions
- Visual impairment (visuele beperking)- Depression (depressie)- Anxiety (angst)
Registration Number
NL-OMON22928
Lead Sponsor
VU University Medical Center
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
230
Inclusion Criteria

1. Informed consent of the participants;

2. Participants must be visually impaired and entered one of the three low vision rehabilitation centres;

Exclusion Criteria

1. Participants with severely impaired cognitive functioning, which will be detected with the 'six-item screener' (a shortened version of the MMSE (Mini-mental state examination) at baseline;

2. Participants with a DSM-IV psychiatric disorder, measured by the Mini (Mini International Neuropsychiatric Interview).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is the cumulative incidence of DSM-IV major depressive or anxiety disorder after 24 months as measured using the Mini International Neuropsychiatric Interview.
Secondary Outcome Measures
NameTimeMethod
Secundary dependent variables are:<br /><br>1. Subthreshold depression and/or anxiety symptoms;<br /><br>2. Vision and health-related quality of life and adaptation to vision loss;<br /><br>3. Process-evaluation outcomes;<br /><br>4. Cost measurement and valuation.<br><br /><br /><br>Secundary independent variables are:<br /><br>1. Socio-demographic and disease variables (age, gender, education, cognitive functioning, co-morbidity, care and low vision aids received in the past half year of the rehabilitation centres etc.).
© Copyright 2025. All Rights Reserved by MedPath